SCM
WGBS

Summit Capital Management’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

Summit Capital Management’s Portfolio WGBS Stock Details WGBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$20K Hold
6,200
– – 0.01% 60
2015
Q4 		$23K Buy
+6,200
New +$30.7K 0.01% 71

Other funds holding WGBS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Summit Capital Management's WGBS Position: Q1 2016 in Review

Summit Capital Management held its WaferGen Bio-systems, Inc. (WGBS) position steady in Q1 2016 at 6,200 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #60.

Summit Capital Management first reported a position in WGBS in Q4 2015 and has held it in 2 quarters since. The position peaked at $23K in Q4 2015. 17 funds tracked by Wall St. Rank hold WGBS as of Q1 2016.

  • Summit Capital Management held 6,200 shares of WaferGen Bio-systems, Inc. worth $20K as of Q1 2016.
  • Summit Capital Management left its WaferGen Bio-systems, Inc. share count unchanged in Q1 2016.
  • WaferGen Bio-systems, Inc. made up 0.01% of Summit Capital Management's portfolio in Q1 2016, its #60 holding.
  • Summit Capital Management first reported a position in WaferGen Bio-systems, Inc. in Q4 2015 and has held it in 2 quarters since.
  • Summit Capital Management's WaferGen Bio-systems, Inc. position peaked at $23K in Q4 2015.
  • 17 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q1 2016.

Based on Summit Capital Management's 13F filing for Q1 2016, filed 11 May 2016.